BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32849659)

  • 1. Measuring the Inducible, Replication-Competent HIV Reservoir Using an Ultra-Sensitive p24 Readout, the Digital ELISA Viral Outgrowth Assay.
    Stuelke EL; James KS; Kirchherr JL; Allard B; Baker C; Kuruc JD; Gay CL; Margolis DM; Archin NM
    Front Immunol; 2020; 11():1971. PubMed ID: 32849659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.
    Passaes CPB; Bruel T; Decalf J; David A; Angin M; Monceaux V; Muller-Trutwin M; Noel N; Bourdic K; Lambotte O; Albert ML; Duffy D; Schwartz O; Sáez-Cirión A
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved assays to measure and characterize the inducible HIV reservoir.
    Massanella M; Yek C; Lada SM; Nakazawa M; Shefa N; Huang K; Richman DD
    EBioMedicine; 2018 Oct; 36():113-121. PubMed ID: 30316868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Suitability of Next-Generation Viral Outgrowth Assays to Measure Human Immunodeficiency Virus 1 Latent Reservoir Size.
    Stone M; Rosenbloom DIS; Bacchetti P; Deng X; Dimapasoc M; Keating S; Bakkour S; Richman DD; Mellors JW; Deeks SG; Lai J; Beg S; Siliciano JD; Pagliuzza A; Chomont N; Lackman-Smith C; Ptak RG; Busch MP
    J Infect Dis; 2021 Oct; 224(7):1209-1218. PubMed ID: 32147687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of the Latent HIV-1 Reservoir Using Ultra Deep Sequencing and Primer ID in a Viral Outgrowth Assay.
    Lee SK; Zhou S; Baldoni PL; Spielvogel E; Archin NM; Hudgens MG; Margolis DM; Swanstrom R
    J Acquir Immune Defic Syndr; 2017 Feb; 74(2):221-228. PubMed ID: 27683060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of the latent HIV-1 reservoir from the sequence diversity in viral outgrowth assays.
    Poon AFY; Prodger JL; Lynch BA; Lai J; Reynolds SJ; Kasule J; Capoferri AA; Lamers SL; Rodriguez CW; Bruno D; Porcella SF; Martens C; Quinn TC; Redd AD
    Retrovirology; 2018 Jul; 15(1):47. PubMed ID: 29976219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of methods to quantify inducible HIV-1 outgrowth.
    Enick PN; Brooker JP; Tumiotto CM; Staines BT; Eron JJ; McMahon DK; Gandhi RT; Mellors JW; Sobolewski MD
    J Virus Erad; 2021 Jun; 7(2):100043. PubMed ID: 34136266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals.
    Wonderlich ER; Subramanian K; Cox B; Wiegand A; Lackman-Smith C; Bale MJ; Stone M; Hoh R; Kearney MF; Maldarelli F; Deeks SG; Busch MP; Ptak RG; Kulpa DA
    PLoS Pathog; 2019 Oct; 15(10):e1008074. PubMed ID: 31609991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size.
    Rosenbloom DIS; Bacchetti P; Stone M; Deng X; Bosch RJ; Richman DD; Siliciano JD; Mellors JW; Deeks SG; Ptak RG; Hoh R; Keating SM; Dimapasoc M; Massanella M; Lai J; Sobolewski MD; Kulpa DA; Busch MP;
    PLoS Comput Biol; 2019 Apr; 15(4):e1006849. PubMed ID: 30978183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads.
    Charlins P; Schmitt K; Remling-Mulder L; Hogan LE; Hanhauser E; Hobbs KS; Hecht F; Deeks SG; Henrich TJ; Akkina R
    Virology; 2017 Jul; 507():135-139. PubMed ID: 28432928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the HIV reservoir with dilution assays and deep viral sequencing.
    Lotspeich SC; Richardson BD; Baldoni PL; Enders KP; Hudgens MG
    Biometrics; 2024 Jan; 80(1):. PubMed ID: 38364812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure.
    Siliciano JD; Siliciano RF
    J Infect Dis; 2021 Feb; 223(12 Suppl 2):13-21. PubMed ID: 33586775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection.
    Rainwater-Lovett K; Ziemniak C; Watson D; Luzuriaga K; Siberry G; Petru A; Chen Y; Uprety P; McManus M; Ho YC; Lamers SL; Persaud D
    PLoS One; 2017; 12(2):e0170548. PubMed ID: 28178277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication competence of virions induced from CD4+ lymphocytes latently infected with HIV.
    Richman DD; Huang K; Lada SM; Sun X; Jain S; Massanella M; Menke B
    Retrovirology; 2019 Feb; 16(1):4. PubMed ID: 30770748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring integrated HIV DNA ex vivo and in vitro provides insights about how reservoirs are formed and maintained.
    Pinzone MR; O'Doherty U
    Retrovirology; 2018 Feb; 15(1):22. PubMed ID: 29452580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of ultrasensitive digital ELISA for p24 enables improved evaluation of HIV-1 reservoir diversity and growth kinetics in viral outgrowth assays.
    Kuzmichev YV; Lackman-Smith C; Bakkour S; Wiegand A; Bale MJ; Musick A; Bernstein W; Aronson N; Ake J; Tovanabutra S; Stone M; Ptak RG; Kearney MF; Busch MP; Wonderlich ER; Kulpa DA
    Sci Rep; 2023 Jul; 13(1):10958. PubMed ID: 37414788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection.
    Pardons M; Baxter AE; Massanella M; Pagliuzza A; Fromentin R; Dufour C; Leyre L; Routy JP; Kaufmann DE; Chomont N
    PLoS Pathog; 2019 Feb; 15(2):e1007619. PubMed ID: 30811499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, Uganda.
    Prodger JL; Lai J; Reynolds SJ; Keruly JC; Moore RD; Kasule J; Kityamuweesi T; Buule P; Serwadda D; Nason M; Capoferri AA; Porcella SF; Siliciano RF; Redd AD; Siliciano JD; Quinn TC
    Clin Infect Dis; 2017 Oct; 65(8):1308-1315. PubMed ID: 28535179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
    Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
    mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vorinostat Renders the Replication-Competent Latent Reservoir of Human Immunodeficiency Virus (HIV) Vulnerable to Clearance by CD8 T Cells.
    Sung JA; Sholtis K; Kirchherr J; Kuruc JD; Gay CL; Nordstrom JL; Bollard CM; Archin NM; Margolis DM
    EBioMedicine; 2017 Sep; 23():52-58. PubMed ID: 28803740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.